Role of macrophages in tuberculous peritonitis: Longitudinal follow-up of 16 continuous ambulatory peritoneal dialysis patients

Hong Kong Journal of Nephrology

Volumn 4, Issue 2, 2002, Pages 90-94

  Chow, Kai Ming ^a   Wong, Wai Shan ^a   Chow, Viola Chi Ying ^a   Wong, Teresa Yuk Hwa ^a   Chan, Natalie Pui Ha ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Leukocytes; Macrophage activation; Mycobacterium tuberculosis; Peritoneal dialysis continuous ambulatory; Phagocytosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CELL COUNT; CELL POPULATION; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DEATH; DEFENSE MECHANISM; FEMALE; FOLLOW UP; HONG KONG; HOST RESISTANCE; HUMAN; HYPOTHESIS; KIDNEY FAILURE; LEUKOCYTE COUNT; LONGITUDINAL STUDY; LYMPHOCYTOSIS; MACROPHAGE FUNCTION; MALE; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PATIENT MONITORING; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; TUBERCULOUS PERITONITIS;

EID: 0036919704     PISSN: 15615413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1561-5413(09)60086-7     Document Type: Article

References (21)

1. Topley N, Liberek T, Davenport A, Li FK, Fear H, Williams JD. Activation of inflammation and leukocyte recruitment into the peritoneal cavity. Kidney Int Suppl 1996;56:S17-21.
2. Coles GA, Williams JD, Topley N. Peritoneal inflammation and long-term changes in peritoneal structure and function. In: Gokal R, Khanna R, Krediet RT, Nolph KD, editors. Textbook of peritoneal dialysis. Dordrecht: Kluwer Academic Publishers; 2000:565-83.
3. Verbrugh HA, Keane WF, Hoidal JR, Freiberg MR, Elliott GR, Peterson PK. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983;147:1018-29.
4. Holmes CJ. Peritoneal host defense mechanisms in peritoneal dialysis. Kidney Int Suppl 1994;48:S58-70.
5. Fenton MJ. Macrophages and tuberculosis. Curr Opin Hematol 1998;5:72-8.
6. McDonough KA, Kress Y, Bloom BR. Pathogenesis of tuberculosis: interaction of Mycobacterium tuberculosis with macrophages. Infect Immun 1993;61:2763-73.
7. Talwani R, Horvath JA. Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and review. Clin Infect Dis 2000;31:70-5.
8. Chow KM, Chow VC, Hung LC, Wong SM, Szeto CC. Tuberculous peritonitis-associated mortality is high among patients waiting for the result of mycobacterial culture of ascitic fluid. Clin Infect Dis 2002;35:409-13.
9. Cheng IKP, Chan PCK, Chan MK. Tuberculous peritonitis complicating long-term peritoneal dialysis. Report of 5 cases and review of the literature. Am J Nephrol 1989;9:155-161.
10. Lui SL, Tang S, Li FK, Choy BY, Chan TM, Lo WK, Lai KN. Tuberculosis infection in Chinese patients undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2001;38:1055-60.
11. Prakash KC. Tuberculous peritonitis. Perit Dial Int 1999;19(Suppl 2):S283-5.
12. O'Connor J, MacCormick M. Tuberculous peritonitis in patients on CAPD: the importance of lymphocytosis in the peritoneal fluid. Perit Dial Bull 1981;1:106.
13. Vas SI. Renaissance of tuberculosis in the 1990s: lessons for the nephrologist. Perit Dial Int 1994;14:209-14.
14. Rapoport J, Hausmann MJ, Chaimovitz C. The peritoneal immune system and continuous ambulatory peritoneal dialysis. Nephron 1999;81:373-80.
15. Goldstein CS, Bomalaski JS, Zurier RB, Neilson EG, Douglas SD. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 1984;26:733-40.
16. Zemel D, Imholz ALT, de Waart DR, Dinkla C, Struijk DG, Krediet RT. Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPD. Kidney Int 1994; 46: 1422-30.
17. Wrenger E, Baumann C, Behrend M, Zamore E, Schindler R, Brunkhorst R. Peritoneal mononuclear cell differentiation and cytokine production in intermittent and continuous automated peritoneal dialysis. Am J Kidney Dis 1998;31:234-41.
18. Peterson PK, Gaziano E, Suh HJ, Devalon M, Peterson L, Keane WF. Antimicrobial activities of dialysate-elicited and resident human peritoneal macrophages. Infect Immun 1985;49:212-8.
19. Chan J, Kaufmann SHE. Immune mechanisms of protection. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington DC: American Society for Microbiology; 1994: 389-407.
20. Parkin J, Cohen B. An overview of the immune system. Lancet 2001;357:1777-89.
21. Abraham G, Mathews M, Sekar L, Srikanth A, Sekar U, Soundarajan P. Tuberculous peritonitis in a cohort of continuous ambulatory peritoneal dialysis patients. Perit Dial Int 2001;21 (Suppl 3):S202-4.